Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine add-on therapy to clozapine in refractory schizophrenia
2011-003466-33Phase 2Completed
- Sponsor
- GGZ Noord-Holland Noord
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of memantine in schizophrenia, sponsored by GGZ Noord-Holland Noord. Primary endpoint: Cognitive functioning. Started Jan 2013; status: completed.
02
Drugs
memantine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2011-003466-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003466-33.